Schizophrenia and mood disorders : the new drug therapies in clinical practice
著者
書誌事項
Schizophrenia and mood disorders : the new drug therapies in clinical practice
Butterworth-Heinemann, 1999
大学図書館所蔵 件 / 全3件
-
該当する所蔵館はありません
- すべての絞り込み条件を解除する
注記
Includes bibliographies and index
内容説明・目次
内容説明
This authoritative reference draws upon, and combines the similarities and differences between European and American practices in the diagnosis and treatment of mood disorders and schizophrenia to provide an international approach to drug therapies. By including the most up-to-date knowledge, best practices, and clinical pearls from each continent, the editors and the 48 international expert contributors have ensured that this is a critical resource for clinicians prescribing for their patients.
The first two sections address the use of a variety of antipsychotic medications for the treatment of schizophrenia, and the clinical use of antidepressant medications and mood stabilizers for depression and mania. The authors discuss their experiences of treatment using some of the most recently available drugs and others which are currently under development. The key issues of concern to the clinician, and broader topics of clinical psychopharmacology, are addressed in the final section which covers underlying principles and offers practical advice.
目次
SECTION I: SCHIZOPHRENIA: Comparative pharmacology of classical and novel (second-generation) antipsychotics (Dr John L Waddington, Dublin
Professor Daniel Casey, Portland)
Traditional antipsychotic medications: contemporary clinical use (Professor S Charles Schulz, Minneapolis
Professor Patrick McGorry, Melbourne)
Clozapine: clinical use and experience (Dr Robert W Buchanan, Baltimore
Dr Peter McKenna, Cambridge)
Risperidone and olanzapine: clinical use and experience (Professor W Wolfgang Fleischhacker, Innsbruck
Professor Stephen R Marder, Los Angeles)
Quetiapine and sertindole: clinical use and experience (Dr Peter F Buckley, Cleveland
Professor Dieter Naber, Hamburg)
Ziprasidone and zotepine: clinical use and experience (Professor Steven Potkin, Irvine
Dr Stephen Cooper, Belfast)
Future directions in novel antipsychotics (Dr Robert Conley, Baltimore)
SECTION 2: DEPRESSION AND MANIA: Synaptic effects of antidepressants: relationships to their therapeutic and adverse effects (Professor Brian E Leonard, Galway
Professor Elliott Richelson, Jacksonville)
Tricyclic antidepressants and classical monoamine oxidase inhibitors: contemporary clinical use (Professor Michael E Thase, Pittsburgh
Professor Willem Nolen, Utrecht)
Selective serotonin reuptake inhibitors: clinical use and experience (Professor Ted Dinan, Dublin
Dr Jeffrey E Kelsey, Atlanta
Professor Charles Nemeroff, Atlanta)
Nefazodone, mirtazapine and venlafaxine: clinical use and experience (Dr Madhukar Trivedi, Dallas
Dr Trisha Suppes, Dallas)
Psychopharmacology of mood stabilizers (Dr Robert Post, Bethseda)
Lithium clinical use in mania and prophylaxis of affective disorders (Dr John Cookson, London
Dr Gary Sachs, Boston)
Carbamazepine and valproate: use in mood disorders (Professor Charles Bowden, San Antonio
Professor Bruno MA1/4ller-Oerlinghausen, Berlin)
Lamotrigine, gabapentin and the new anticonvulsants: efficacy in mood disorders (Professor Nicol Ferrier, Newcastle
Professor Joseph Calabrese, Cleveland)
Antipsychotic medications in the treatment of mood disorders (Professor Paul Keck, Jr, Cincinnati
Professor Rasmus W Licht, Risskov)
Future directions in novel antidepressants and mood stabilizing agents (Professor Siegfried Kasper, Vienna
Professor Alan Schatzberg, Stanford)
SECTION 3: KEY ISSUES IN CLINICAL PSYCHOPHARMACOLOGY: Drug interactions (Professor David J King, Belfast)
Psychotropic drugs during pregnancy (Dr Sheila Marcus, Ann Arbor
Dr Rajiv Tandon, Ann Arbor)
Psychopharmacology in the young (Dr Sophia Frangou, London
Dr Sanjiv Kumra, Toronto)
Drug treatment of schizophrenia and mood disorders in older people (Dr Ruth Allen, London
Dr Barbora Richardson, London
Dr Tim Stevens, London
Professor Cornelius Katona, London)
Treatment of substance misuse in schizophrenia (Professor Kim Mueser, Concord
Professor ShA'n Lewis, Manchester)
Treating violence in the context of psychosis (Professor Pamela J Taylor, London
Dr Peter F Buckley, Cleveland)
Poor compliance with treatment in people with schizophrenia: causes and management (Professor Thomas RE Barnes, London
Dr Daniel Andrews, London
Professor A George Awad, Toronto)
Pharmacoeconomics and resource allocation: lessons from North America (Dr William Glazer, Boston
Dr Ruth Dickson, Calgary).
「Nielsen BookData」 より
